Ensign Peak Advisors, Inc X4 Pharmaceuticals, Inc Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 2,235,655 shares of XFOR stock, worth $5.77 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,235,655
Previous 2,546,458
12.21%
Holding current value
$5.77 Million
Previous $1.96 Million
72.65%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XFOR
# of Institutions
18Shares Held
22.3MCall Options Held
45.8KPut Options Held
0-
Black Rock Inc. New York, NY10.7MShares$27.5 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD500KShares$1.29 Million0.08% of portfolio
-
Sv Health Investors, LLC Boston, MA311KShares$803,6441.65% of portfolio
-
Ajo Vista, LLC Boston, MA258KShares$664,7210.75% of portfolio
-
Jpmorgan Chase & CO New York, NY165KShares$426,8300.0% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $177M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...